openPR Logo
Press release

Global Cancer Biomarkers Market, by Product types (Protein Biomarker, Genetic Biomarker, Other Cancer Biomarkers (cell, viral, and carbohydrate biomarkers), by Application (Diagnostics, Research, Prognostics, Risk Assessment, Other Applications (personali

01-05-2021 09:48 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from:

Cancer Biomarkers Market

Cancer Biomarkers Market

Global Cancer Biomarkers Market was valued at US$ 14.56 billion in 2019 and is projected to reach US$ 32.59 billion by 2025, at a CAGR of 12.2% during the forecast period. Significant growth of biological & targeted drug therapies, technological advancements, improved accuracy and reliability of cancer biomarkers, along with increase in reported cases of breast, prostate, and lung cancer have contributed for the growth of the global cancer biomarker market.

North America led the cancer biomarker market in 2019. Increased adoption of cancer biomarkers for diagnosis and treatment, coupled by the high incidence rate of cancer in the region propels the market growth. Moreover, various cancer biomarker diagnostics are covered under health insurance in the region which contribute to the increase in usage. However, the cancer biomarker market in Asia-Pacific is anticipated to grow at the fastest rate during the forecast period, owing to increase in incidence rate of cancer in China and Japan. Moreover, rise in awareness and affordability for advanced cancer treatments further boosts the Asia-Pacific cancer biomarkers market.

Deep analysis about Global Cancer Biomarkers market status (2016-2019), competition pattern, advantages and disadvantages of products, industry development trends (2019-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to downstream buyers of this industry have been analysed scientifically. This report will help you to establish comprehensive overview of the Cancer Biomarkers Market

Report Link
For more details on “Cancer Biomarkers” Market Report:

What this report Offers
This report covers an in-depth analysis of the Cancer Biomarkers market including statistical and qualitative data points with emphasis on the market dynamics including the drivers, opportunities & restraints.

There is a coverage of market dynamics at country level in the respective regional segments. The report comprises competitive analysis with focus on key players and participants of Cancer Biomarkers market covering in-depth data related to competitive landscape, positioning, company profiles, key strategies adopted and product-profiling with focus on market growth and potential.

To avail a copy of the sample of the Cancer Biomarkers Market Report:

Key Segmentations in this report
Global Cancer Biomarkers Market, by Players
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Roche Diagnostics
• Qiagen N.V.
• Illumina
• GE Healthcare
• Agilent Technologies
• Biomérieux SA
• Merck & Co.
• Abbott Laboratories
• Becton, Dickinson and Company
• Danaher Corporation
• Myriad Genetics
• Sysmex Corporation
• Hologic
• Quest Diagnostics

Global Cancer Biomarkers Market, by Product Types
• Protein Biomarker
• Genetic Biomarker
• Other Cancer Biomarkers (cell, viral, and carbohydrate biomarkers)

Global Cancer Biomarkers Market, by Application
• Diagnostics
• Research
• Prognostics
• Risk Assessment
• Other Applications (personalized medicine, surrogate endpoints, and therapeutics)

For a detailed table of content of the Cancer Biomarkers Market Report:

"Contact Us
Tollfree: +1-800-123-3008

Mailing Address
Unit A-1, 1st Floor, Snehajyoti, No 37,
Srinivagalu Main Road, Ejipura,
Viveknagar, Bengaluru, India, 560047"

"About Us
A fact-based research and consulting firm, i2iResearch helps companies in realising their strategic goals by empowering them to make decisions driven by accurate information, intelligence, and insights.

We specialize in providing deep market insights that help our clients in getting an in-depth understanding of how different factors impact their business and the industry that they are in or planning to get into. As a result, we are able to help you always stay ahead of the curve and achieve a sustained revenue growth with healthy bottomline."

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cancer Biomarkers Market, by Product types (Protein Biomarker, Genetic Biomarker, Other Cancer Biomarkers (cell, viral, and carbohydrate biomarkers), by Application (Diagnostics, Research, Prognostics, Risk Assessment, Other Applications (personali here

News-ID: 2220666 • Views: 418

More Releases from

Global Cloud Storage Market, by Component (Services, Solution), by Deployment Ty …
Global Cloud Storage Market was valued at US$ 46.12 million in 2019 and is projected to reach US$ 184.47 million by 2025, at a CAGR of 21.9% during the forecast period. Exponential growth in cloud data volumes in recent years is driving the demand for cloud storage solutions. The demand for cloud storage was highest from the BFSI industry. Coupled with data security, agility, and scalability the need for operational
Global Coiled Tubing Market, by service (Well intervention, Well Cleaning & Pump …
Global Coiled Tubing Market was valued at US$ 3 billion in 2019 and is projected to reach US$ 4.45 billion by 2025, at a CAGR of 5.8% during the forecast period. The increase in E&P activities in unconventional oil & gas reserves is anticipated to remain the key factor for market growth. Rising demand for primary energy for transportation, power generation, and household activities has resulted in increased consumption of
Global Coal Bed Methane CBM Market, by Technology (Hydraulic Fracturing, Horizon …
Global Coal Bed Methane CBM Market was valued at US$ 16 billion in 2019 and is projected to reach US$ 23.90 billion by 2025, at a CAGR of 5.9% during the forecast period. Shift in trend towards reducing reliance on conventional gas coupled with government support in the form of tax benefits and financial incentives is expected to boost CBM production over the forecast period. The increasing consumer demand for
Global Bone Growth Stimulator Market, by Product types (Bone Growth Stimulation …
Global Bone Growth Stimulator Market was valued at US$ 1.14 billion in 2019 and is projected to reach US$ 1.65 billion by 2025, at a CAGR of 5.4% during the forecast period. Rising incidence of arthritis, osteoporosis, and bone fractures is one of the major factors expected to propel the market growth. Bone growth stimulators have various applications, such as in spinal fusion surgeries, in case of delayed union &

All 5 Releases

More Releases for Biomarker

Brain Biomarker Market 2021 | Detailed Report
The Brain Biomarker research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Brain Biomarker research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force. Get Free Sample PDF (including full
Global Biomarker Market 2021 : Clinical Diagnostic, Drug Discovery, Diagnostic B …
This "Biomarker Market" to portray important bits of knowledge identified with critical market patterns driving the business. The Biomarker report incorporates a scope of inhibitors just as main impetuses of the market which are broke down in both subjective and quantitative methodology so perusers and clients get exact data and experiences about industry. Factual information referenced in the report is represented with the assistance of diagrams which improves on the
Impact of Outbreak of Coronavirus (Covid-19) on Biomarker Technologies Market 20 …
The Biomarker Technologies market is expected to reach USD 92 Billion by 2027 from USD 60 Billion in 2019, at a CAGR of 10% during the forecast period. A comprehensive report on Biomarker Technologies Market was published by Research N Reports to understand the complete setup of Biomarker Technologies Market industries. Effective qualitative and quantitative analysis techniques have been used to examine the data accurately. Variable factors that comprise basis
Biomarker Technologies Market – Major Technology Giants in Buzz Again | Biomar …
A New Research on the Global Biomarker Technologies Market was conducted across a variety of industries in various regions to produce more than 150 page reports. This study is a perfect blend of qualitative and quantifiable information highlighting key market developments, industry and competitors' challenges in gap analysis and new opportunities and may be trending in the Biomarker Technologies market. Some are part of the coverage and are the core
Global Cancer Biomarker Market Advantages & Developments 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports. The global Cancer Biomarker market has been exclusively and elaborately examined in this report while taking into account some of the most pivotal factors holding the capability to influence growth. For the said forecast tenure, the report has shed light on critical market dynamics, which include trends, opportunities, restraints, and
Biomarker Technologies Market : Analysis & Trends 2025
A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological